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Abstract​: The volume and complexity of diagnostic imaging is increasing at a pace faster than the 
availability of human expertise to interpret it. Artificial intelligence has shown great promise in 
classifying two-dimensional photographs of some common diseases and typically relies on databases of 
millions of annotated images. Until now, the challenge of reaching the performance of expert clinicians 
in a real-world clinical pathway with three-dimensional diagnostic scans has remained unsolved. Here, 
we apply a novel deep learning architecture to a clinically heterogeneous set of three-dimensional 
optical coherence tomography (OCT) scans from patients referred to a major eye hospital. We 
demonstrate performance in making a referral recommendation that reaches or exceeds that of experts 
on a range of sight-threatening retinal diseases after training on only 14,884 scans. Moreover, we 
demonstrate that the tissue segmentations produced by our architecture act as a device-independent 
representation; referral accuracy is maintained when using tissue segmentations from a different type of 
device. Our work removes previous barriers to wider clinical use without prohibitive training data 
requirements across multiple pathologies in a real-world setting.  
Introduction 
Medical imaging is expanding globally at an unprecedented rate​1,2​, leading to an ever-expanding quantity of data 
requiring human expertise and judgement to interpret and triage. In many clinical specialities there is a relative 
shortage of this expertise to provide timely diagnosis and referral. For example, in ophthalmology, the 
widespread availability of optical coherence tomography (OCT) has not been matched by the availability of 
expert humans to interpret scans and refer patients to the appropriate clinical care​3​. This problem is exacerbated 
by the dramatic increase in prevalence of sight-threatening diseases for which OCT is the gold standard of initial 
assessment​4–7​.  
 
Artificial intelligence (AI) provides a promising solution for such medical image interpretation and triage, but 
despite recent breakthroughs demonstrating expert-level performance on two-dimensional photographs in 
preclinical settings​8,9​, prospective clinical application of this technology remains stymied by three key 
challenges. First, AI (typically trained on hundreds of thousands of examples from one canonical dataset) must 
generalise to new populations and devices without a substantial loss of performance, and without prohibitive 
data requirements for retraining. Second, AI tools must be applicable to real-world scans, problems and 
pathways, and designed for clinical evaluation and deployment. Finally, AI tools must match or exceed the 
performance of human experts in such real-world situations. Recent work applying AI to OCT has shown 
promise in resolving some of these criteria in isolation, but has not yet shown clinical applicability by resolving 
all three. 
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Results 
Clinical Application & AI architecture 
We developed our architecture in the challenging context of optical coherence tomography (OCT) imaging for 
ophthalmology. We tested this approach for patient triage in a typical ophthalmology clinical referral pathway, 
comprising more than 50 common diagnoses for which OCT provides the definitive imaging modality 
(​Supplementary Table 1​)​. OCT is a three-dimensional volumetric medical imaging technique analogous to 3D 
ultrasonography but measuring the reflection of near-infrared light rather than sound waves at a resolution for 
living human tissue of ~5 µm​10​. ​OCT is now one of the most common imaging procedures with 5.35 million 
OCT scans performed in the U.S. Medicare population in 2014 alone (see 
https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-C
harge-Data/Physician-and-Other-Supplier.html​). It has been widely adopted across the UK National Health 
Service (NHS) for comprehensive initial assessment and triage of patients requiring rapid non-elective 
assessment of acute and chronic sight loss. Rapid access “virtual” OCT clinics have become the standard of 
care​11,12 ​. In such clinics, expert clinicians interpret the OCT and clinical history to diagnose and triage patients 
with pathology affecting the macula, the central part of the retina required for high-resolution, color vision.  
 
Automated diagnosis of a medical image, even for a single disease, faces two main challenges: technical 
variations in the imaging process (different devices, noise, ageing of the components, etc.), and 
patient-to-patient variability in pathological manifestations of disease. Existing deep learning approaches​8,9​ seek 
to deal with all combinations of these variations using a single end-to-end black-box network, thus typically 
requiring millions of labeled scans. In contrast, our framework decouples the two problems (technical variations 
in the imaging process, and pathology variants) and solves them independently (see ​Fig. 1​). A deep 
segmentation network (​Fig. 1b​) creates a detailed device-independent tissue segmentation map. Subsequently, a 
deep classification network (​Fig. 1d​) analyses this segmentation map and provides diagnoses and referral 
suggestions. 
 
 
 
Figure 1 | Our proposed AI framework.​ (​a​) Raw retinal OCT scan (6 x 6 x 2.3 mm³ around the macula). (​b​) Deep 
segmentation network, trained with manually segmented OCT scans.  (​c​) Resulting tissue segmentation map. (​d​) Deep 
classification network, trained with tissue maps with confirmed diagnoses and optimal referral decisions. (​e​) Predicted diagnosis 
probabilities and referral suggestions. 
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Figure 2 | Results of the segmentation network. ​Three selected 2D slices from the n=224 OCT scans in the segmentation 
test set (left column) with manual segmentation (middle column) and automated segmentation (right column; detailed ​color 
legend in ​Supplementary Table 2​)​. (​a​) A patient with diabetic macular edema. (​b​) A patient with choroidal neovascularization 
resulting from age-related macular degeneration (AMD), demonstrating extensive fibrovascular pigment epithelium detachment 
and associated subretinal fluid. ​(c)​ A patient with neovascular AMD with extensive subretinal hyperreflective material. Further 
examples of the variation of pathology with model segmentation and diagnostic performance can be found in ​Supplementary 
Videos 1-9​. In all examples the classification network predicted the correct diagnosis. Scale bars: 0.5mm 
 
 
The segmentation network (​Fig. 1b​) uses a 3D U-Net architecture​13,14​ to translate the raw OCT scan into a tissue 
map (​Fig. 1c​) with 15 classes including anatomy, pathology and image artefacts (​Supplementary Table 2​). It 
was trained with 877 clinical OCT scans (Topcon 3D OCT, Topcon, Japan) with sparse manual segmentations 
(Dataset #1 in ​Supplementary Table 3, ​see ​Online Methods “Manual Segmentation” and "Datasets" ​for 
full breakdown of scan dataset). Only approximately 3 representative slices of the 128 slices of each scan were 
manually segmented (see ​Supplementary Table 4​ for image sizes) . This sparse annotation procedure​14​ allowed 
us to cover a large variety of scans and pathologies with the same workload as approximately 21 dense manual 
segmentations. Examples of the output of our segmentation network for illustrative pathologies are shown in 
Fig. 2​.  
 
The classification network (​Fig. 1d​) analyses the tissue segmentation map (​Fig. 1c​) and as a primary outcome 
provides one of four referral suggestions currently used in clinical practice at Moorfields Eye Hospital (please 
see ​Supplementary Table 1 ​for a list of retinal conditions associated with these referral suggestions). 
Additionally, it reports the presence or absence of multiple, concomitant retinal pathologies (​Supplementary 
Table 5​). To construct the training set for this network we assembled 14,884 OCT scan volumes of 7621 
patients referred to the hospital with symptoms suggestive of macular pathology (see ​Online Methods 
"Clinical Labeling"​ for details). These OCT scans were automatically segmented using our segmentation 
network. The resulting segmentation maps with the clinical labels built the training set for the classification 
network (Dataset #3 in ​Supplementary Table 3, ​illustrated in​ Fig. 1d​). 
 
A central challenge in OCT image segmentation is the presence of ambiguous regions, where the true tissue type 
cannot be deduced from the image, and thus multiple equally plausible interpretations exist. To address this 
issue, we trained not one but multiple instances of the segmentation network. Each network instance creates a 
full segmentation map for the given scan, resulting in multiple hypotheses (see ​Supplementary Fig. 1​). 
Analogous to multiple human experts, these segmentation maps agree in areas with clear image structures but 
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may contain different (but plausible) interpretations in ambiguous low-quality regions. These multiple 
segmentation hypotheses from our network can be displayed as a video, where the ambiguous regions and the 
proposed interpretations become clearly visible (see ​Online Methods "Visualization of results in clinical 
practice"; ​use of this viewer across a range of challenging macular diseases is illustrated in ​Supplementary 
Videos 1-9​). 
Achieving Expert Performance on Referral Decisions 
To evaluate our framework, we first defined a gold standard. This used information not available at the first 
patient visit and OCT scan, by examining the patient clinical records to determine the final diagnosis and 
optimal referral pathway in the light of that (subsequently obtained) information. Such a gold standard can only 
be obtained retrospectively. Gold standard labels were acquired for 997 patients not included in the training 
dataset (Dataset #5 in ​Supplementary Table 5). ​We then tested our framework on this dataset. For each patient, 
we obtained the referral suggestion of our framework plus an independent referral suggestion from eight clinical 
experts, four of whom were retina specialists and four optometrists trained in medical retina; see 
Supplementary Table 6​ for more information. Each expert provided two separate decisions, one (like our 
framework) from the OCT scan alone (Dataset #7 in ​Supplementary Table 5​); and one from the OCT plus 
fundus image and clinical notes (Dataset #8 in ​Supplementary Table 5, ​see ​Supplementary Fig. 2​), in two 
separate sessions spaced at least two weeks apart. We compared each of these performances (framework and 
two expert decisions) against the gold standard.  
 
Our framework achieved and in some cases exceeded expert performance (​Fig. 3​). To illustrate this, ​Fig. 3a 
displays performance on "Urgent referrals", the most important clinical referral decision (mainly due to 
pathologies that cause choroidal neovascularization (CNV) -- see ​Supplementary Table 1​) versus all other 
referral decisions as a receiver operating characteristic (ROC) plot (plots for the other decisions are shown in 
Supplementary Fig. 3​). Performance of our framework matched our two best retina specialists and had a 
significantly higher performance than the other two retinal specialists and all four optometrists when they used 
only the OCT scans to make their referral suggestion. (​Fig. 3a​ filled markers). When experts had access to the 
fundus image and patient summary notes to make their decision, their performance improved (​Fig. 3a​ empty 
markers) but our framework remained as good as the five best experts and continued to significantly outperform 
the other three (see Supplemental Material).  
 
To provide a fuller picture, the overall performance of our framework on all four clinical referral suggestions 
("urgent", "semi-urgent", "routine", and "observation only") is displayed in ​Fig. 3b​ compared to the two highest 
performing retina specialists. The framework performed comparably to the two best-performing retina 
specialists, and made no clinically serious wrong decisions (topright element of each matrix, i.e. referring a 
patient who needs an urgent referral to observation only). Confusion matrices for the assessments of the other 
human experts are shown in ​Supplementary Fig. 4​. The aggregated number of wrong referral decisions is 
displayed as error rate (1 - accuracy) for our framework and all experts in ​Fig. 3c​. Our framework (5.5% error 
rate) performed comparably to the two best retina specialists (6.7% and 6.8% error rate) and significantly 
outperformed the other six experts in the "OCT only" setting. Significance thresholds (3.9% for higher 
performance and 7.3% for lower performance) were derived by a two-sided exact binomial test, incorporating 
uncertainty both from expert and from algorithm (see ​Online Methods​ ​"Statistical Analysis"​). When experts 
additionally used the fundus image and the patient’s summary notes, five approached the performance of our 
framework (three retina specialists and two optometrists), which continued to significantly outperform the 
remaining three (one retina specialist and two optometrists). 
 
Our framework uses an ensemble of five segmentation and five classification model instances (see 
Supplementary Fig. 1​) to achieve these results. Beside the benefits of an uncertainty measure, ensembling also 
significantly improves overall performance compared to a single model instance. Error rates for different 
ensemble sizes are shown in ​Supplementary Fig. 5. ​With more segmentation model instances and more 
classification model instances, performance increases. The bottom right cells in that table illustrate that 
performance differences between 4 x 4 model instances and 5 x 5 model instances are only marginal, so we do 
not expect significant changes by adding more instances.  
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Figure 3 | Results on the patient referral decision.​ ​Performance ​on an independent test set of n=997 patients (252 urgent, 
230 semi-urgent, 266 routine, 249 observation only). (​a​) Receiver operating characteristic (ROC) diagram for "urgent referral" 
(due to choroidal neovascularization (CNV)) versus all other referrals. The blue ROC curve is created by sweeping a threshold 
over the predicted probability of a particular clinical diagnosis. Points outside the light blue area correspond to a significantly 
different performance (95% confidence level, using a two-sided exact binomial test). The asterisk denotes the performance of 
our model in the 'balanced performance' setting. Filled markers denote experts' performance using OCT only; emptyoutlined 
markers denote their performance using OCT, fundus image and summary notes. Dashed lines connect the two performance 
points of each expert. (​b​) Confusion matrices with patient numbers for referral decision for our framework and the two best 
retina specialists. These show the number of patients for each combination of gold standard decision and predicted decision. 
The numbers of correct decisions are found on the diagonal. Wrong decisions due to overdiagnosis are in the lower-left triangle, 
and wrong decisions due to underdiagnosis are in the upper-right triangle. (​c​) Total error rate (1 - accuracy) on referral decision. 
Values outside the light blue area (3.9% - 7.3%) are significantly different (95% confidence interval, using a two-sided exact 
binomial test) to the framework performance (5.5%). AUC: area under curve. 
 
 
The accumulated number of diagnostic errors does not fully reflect the clinical consequences that an incorrect 
referral decision might have for patients, which depends also on the specific diagnosis missed. For example, 
failing to diagnose sight-threatening conditions could result in rapid visual loss​3,15,16​ which is not the case for 
many other diagnoses. For an initial quantitative estimation of these consequences, we weighted different types 
of diagnostic errors according to our clinical experts’ judgement of the clinical impact of erroneous 
classification (expressed as penalty points; see ​Supplementary Fig. 6a​). We derived a score for our framework 
and each expert as a weighted average of all wrong diagnoses. This revealed that our framework achieved a 
lower average penalty point score than any of our experts (​Supplementary Fig. 6b​). We further optimized our 
framework decisions to minimise this specific score (see ​Online Methods "Optimizing the Ensemble Output 
for Sensitivity, Specificity and Penalty Scores"​) which further improved performance (​Supplementary Fig. 
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6b​). Thus the expert performance of our framework is not achieved at the cost of missing clinically important 
sight-threatening diagnoses.  
 
To examine how our proposed two-stage architecture compared to a traditional single-stage architecture, we 
trained an end-to-end classification network with the same architecture as our second stage to map directly from 
a raw OCT scan to a referral decision (see ​Methods "End-to-end Classification Network"​). The error rate 
achieved with an ensemble of five network instances was 5.5%, which was not significantly different from the 
performance of the two-stage architecture. This validates our choice of the two-stage architecture that offers 
several clinical advantages. See ​Supplementary Fig. 7​ for detailed results. 
Achieving Expert Performance on Retinal Morphology  
The referral decision recommended by our framework is determined by the most urgent diagnosis detected on 
each scan (​Supplementary Table 1​). Patients may also have multiple concomitant retinal pathologies. These 
additional pathologies do not change the referral decision, but may have implications for further investigations 
and treatment. Our framework was therefore also trained to predict the probability of a patient having one or 
more of several pathologies (​Supplementary Table 5​).  
 
To evaluate performance on diagnosing multiple pathologies, a ‘silver standard’ for each scan was established 
by majority vote from eight experts who evaluated the OCT scan, fundus image and patient summary notes 
(Dataset #6 in ​Supplementary Table 3)​. This majority vote biases the assessment against our framework. 
Nevertheless, our framework demonstrated an area under the ROC curve that was over 99% for most of the 
pathologies (and over 96% for all of them; ​Supplementary Table 7​), on par with the experts' performance on 
OCT only. As with earlier evaluations, experts’ performance improved when they were provided also with the 
fundus image and patient summary notes. This improvement was most marked in pathologies classed as 'routine 
referral' e.g. geographic atrophy and central serous retinopathy. Many of these are conditions where the fundus 
photograph or demographic information would be expected to provide important information, indicating that 
there is scope for future work to improve the model. However even in the worst case our framework still 
performed on par with at least one retinal specialist and one optometrist (​Supplementary Table 6 ​and 
Supplementary Fig. 8​).  
Generalization to a New Scanning Device Type 
A key benefit of our two-stage framework is the device independence of the second stage. ​Using our framework 
on a new device generation ​thus only requires retraining of the segmentation stage to learn how each tissue type 
appears in the new scan, while knowledge about patient-to-patient variability in pathological manifestation of 
different diseases that it learned from the approximately 15,000 training cases can be reused. To demonstrate 
this generalization, we collected an independent test set of clinical scans from 116 patients (plus confirmed 
clinical outcomes) recorded with a different OCT scanner type from a different vendor (Spectralis, Heidelberg 
Engineering, Germany; hereafter “device type 2”) . This dataset is listed as Dataset #11 in ​Supplementary 
Table 3 ​(see also ​Online​ ​Methods "Datasets"​ for details). We selected this device type for several reasons. It 
is the second most used device type at Moorfields Eye hospital for these examinations, giving rise to a sufficient 
number of scans. It has a similar worldwide market share as device type 1. But most importantly, this device 
type ​provides a large difference in scan characteristics compared to ​the original device type (see 
Supplementary Fig. 9​).  
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Figure 4 | Generalization to a new scanning device type. ​(​a​) Low performance of original network on OCT scans from the 
new device type 2. Left: The selected slice shows the different appearance of structures in device type 2.  Middle: A poor quality 
segmentation map created with our original segmentation network ​(​color legend in ​Supplementary Table 2​). Right: Resulting 
performance on a new test set of n=116 patients. The confusion matrix shows patient numbers for the referral suggestion. (​b​) 
All five segmentation hypotheses from our original network. The strong variations show the large uncertainty. (​c​) High 
performance was attained on the device type 2 test set (n=116) after re-training the segmentation network with OCT scans from 
device type 1 and device type 2. The classification network is unchanged. (​d​) All five segmentation hypotheses from the 
re-trained segmentation network. The network is confident in the interpretation of most structures, and just highlights the 
ambiguities in the sub-retinal pigment epithelium (RPE) space. Scale bars: 0.5mm 
 
 
To evaluate the effect of a different scanning device type, we initially fed the OCT scans from device type 2 into 
our framework trained only on scans from device type 1 (​Fig. 4a​). The segmentation network is clearly 
confused by the changed appearance of these structures and attempted to explain them as additional retinal 
layers (​Fig. 4a​ middle). Consequently, performance was poor with a total error rate for referral suggestions of 
46.6% (​Fig. 4a​ right). Uncertainty of the segmentation network on these (never seen) types of images resulted in 
five strongly different segmentation hypotheses (​Fig. 4b​).  
 
We next collected an additional segmentation training set with 152 scans (527 manually segmented slices in 
total) from this device (Dataset #9 in ​Supplementary Table 3)​, and retrained the segmentation network with 
both the training scans from the original device type 1 and the new device type 2 (see ​Online Methods 
"Segmentation Network" ​for details). The classification network was not modified. 
 
Our retrained system (adapted segmentation network + unchanged classification network) now achieved a 
similarly high level of performance on device type 2 as on the original device (​Fig. 4c​). It suggested incorrect 
referral decisions in 4 of the 116 cases, a total error rate of 3.4%. Due to the small number of cases in the new 
test set, this is not significantly different to the error rate of 5.5% on device type 1 (P(4 out of 116 < 55 out of 
997) = 0.774, see ​Online Methods "Statistical Analysis"​). For continuity with our previous evaluation, we 
also measured performance against retina specialists accessing OCT scans plus fundus images and clinical notes 
(Dataset #12 in ​Supplementary Table 3​). Our experts achieved the following error rates (all with access to 
imaging and clinical notes): retinal specialist one: 2 errors = 1.7% error rate; retinal specialist two: 2 errors = 
1.7% error rate; retinal specialist three: 4 errors = 3.4% error rate; retinal specialist four: 3 errors = 2.6% error 
rate; retinal specialist five: 3 errors = 2.6% error rate. These differences in performance between our framework 
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and the best human retina specialists did not reach statistical significance (P(4 out of 116 > 2 out of 116) = 
0.776).  
 
To verify that device type 2 provides the greatest difference in scan characteristics, we performed a feasibility 
study on the small number of OCT scans from Cirrus HD-OCT 5000 with AngioPlex (Carl Zeiss Meditec) 
devices available in Moorfields Eye Hospital (dataset of 61 scans not included here). Applying our original 
network to these images we already obtained an error rate of 16.4%. This rate was much lower than that 
originally obtained with device type 2 (46.6%), consistent with the claim that device type 2 provides a larger 
difference in scan characteristics from device type 1. Retraining of the segmentation network with 6 manually 
segmented scans reduced the error rate to 9.8%. 
 
Table 1​ summarizes our results: For device type 1 our architecture required 877 training scans with manual 
segmentations and 14,884 training scans with gold standard referral decisions to achieve expert performance on 
referral decisions (5.5% error rate). For device type 2 we only required 152 additional training scans with 
manual segmentations and not a single additional training scan with gold standard referral decisions to achieve 
the same performance on referral decisions on this device type (3.4% error rate).  
 
 
Table 1 | Number of training scans and achieved performance on the two device types 
 
 
Training 
Scans with sparse 
manual segmentations 
Training 
Scans with gold 
standard referral 
decision 
Test 
Performance on  
referral decision 
(error rate) 
Test 
Performance on 
urgent referral 
(AUC) 
Device type 1 877 14,884 55 out of 997 = ​5.5% 99.21 
Device type 2 152  
(+ 877 scans from 
device type 1) 
0   4 out of 116 = ​3.4% 99.93 
 
 
Discussion 
Recent work applying AI to the automated diagnosis of OCT scans shows encouraging results but until now 
such studies have relied on selective and clinically unrepresentative OCT datasets. For example, several 
authors​17–21​ report high performance on automated classification of age-related macular degeneration (AMD) 
from OCT scans. However, they tested their algorithms on smaller datasets that exclude other pathologies. In 
contrast, here we demonstrate expert performance on multiple clinical referral suggestions for two independent 
test datasets of 997 and 116 clinical OCT scans that include a wide range of retinal pathologies.  
 
Several recent studies used deep learning based architectures to deliver successful segmentation of OCT 
scans​22–25​. This earlier work focused on a subset of diagnostically relevant tissues types (e.g. intraretinal fluid) 
and applied 2D models in samples of between 10 and 42 patients. In the present work we go beyond these 
earlier studies by applying 3D models, segmenting a much larger range of diagnostically relevant tissue types, 
and connect such segmentation to clinically relevant real-world referral recommendations.  
 
We evaluated our framework on a broad range of real-world images from routine clinical practice at 32 different 
Moorfields Eye Hospital sites covering diverse populations within London and surrounding areas, using 37 
individual OCT devices (28 device type 1 and 9 device type 2). The two device types we tested are both used 
widely in routine clinical practice at Moorfields Eye Hospital, the largest eye hospital in Europe and North 
America, and provided a large difference in scan characteristics.  
 
A number of potential benefits extend from our framework. The derivation of a device-independent 
segmentation of the OCT scan creates an intermediate representation that is readily viewable by a clinical expert 
and integrates into clinical workflows (see ​Fig. 5​ for the clinical results viewer). Moreover, the use of an 
ensemble of five segmentation network instances allows us to present ambiguities arising from the imaging 
process to the decision network (and could potentially be used for automated quality control).  
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Figure 5 | Visualization of the segmentation results as thickness maps.​ (​a​) The average intensity projection of the OCT 
scan along A-scan direction (frontal view of the eye) is overlaid with a thickness map of the fibrovascular pigment epithelium 
detachment (PED,red segment). (​b​) Screenshot from our OCT viewer. (​Row 1 left​) Referral suggestion, tissue volumes and 
diagnosis probabilities. The highlighted bars correspond to the selected segmentation model. (​Rows 1-3)​ Thickness maps of 
the 10 relevant tissue types from segmentation model instance 2. The two healthy tissue types (high level retina and RPE) are 
displayed in a black-blue-green-brown-white color map, the pathological tissues (all others) are displayed as overlay on a 
projection of the raw OCT scan. The thin white line indicates the position of slice 80. (​Row 4​) Slice 80 from the OCT scan and 
the segmentation map from segmentation model instance 2. Detailed tissue legend in ​Supplementary Table 2​. The slice and 
model instance can be interactively selected (see ​Supplementary Video 1​). 
 
 
The ‘black box’ problem has been identified as an impediment to the application of deep learning in 
healthcare​26​. Here we created a framework whose structure closely matches the clinical decision-making 
process, separating judgements about the scan itself from the subsequent referral decision. This allows a 
clinician to inspect and visualize an interpretable segmentation, rather than simply being presented with a 
diagnosis and referral suggestion. Such an approach to medical imaging AI offers potential insights into the 
decision process, in a fashion more typical of clinical practice. For example, an interpretable representation is 
particularly useful in difficult and ambiguous cases. Such cases are common in medicine and even expert 
medical practitioners can find it difficult to reach consensus (for example, our eight experts only agreed on 
63.5% of cases even when accessing all information).  
 
Our segmentation map assigns only one label per pixel, and it may not be possible to use the framework directly 
in other clinical pathways where the tissue segmentation map does not contain all required information for a 
diagnosis (e.g. in certain radiomics applications). To keep the advantages of the intermediate 
device-independent representation in such applications, future work can potentially augment the tissue 
segmentation map with multiple labels per pixel to encode local tissue features, or with additional channels that 
encode continuous features like inflammatory reaction. This may be of particular value for other components of 
the retina such as the nerve fibre layer, and may be of importance for multiple ocular and brain disorders such as 
glaucoma and dementia. 
 
While we have demonstrated the performance of our framework in the domain of a clinical treatment pathway, 
the approach has potential utility in clinical training where medical professionals must learn to read medical 
images. In addition, a wide variety of non-medically qualified health professionals have an interest in 
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appropriately reading and understanding medical images. Our framework produces a visualisable segmentation 
and achieves expert performance on diagnosis and referral decisions for a large number of scans and 
pathologies. This therefore raises the intriguing possibility that such a framework could be evaluated as a tool 
for effectively training health care professionals to expert levels.  
 
Segmentation output itself can also be used to quantify retinal morphology and derive measurements of 
particular pathologies (for example, the location and volume of fibrovascular pigment epithelium detachment 
and macular edema). Some of these measurements (such as retinal thickness and intraretinal fluid) can currently 
be derived automatically​27,28 ​, used to investigate correlations with visual outcomes​27​ and as an endpoint in 
clinical trials of therapies for retinal disease​29–32​. Our framework can be used to define and validate a broader 
range of automatically derived quantitative measurements.  
 
Our framework can triage scans at first presentation of a patient into a small number of pathways used in routine 
clinical practice with a performance matching or exceeding both expert retina specialists and optometrists who 
staff virtual clinics in a UK NHS setting. Future work can now directly seek evidence for efficacy of such a 
framework in a randomized controlled trial. The output of our framework can be optimized to penalize different 
diagnostic errors, and thus for other clinically important metrics. For example, the potential improvement to 
patient quality of life of different diagnostic decisions, or avoiding the harm of unnecessary investigation that 
might come from a false-positive diagnosis, could all be incorporated into future work.  
 
Globally, ophthalmology clinical referral pathways vary, and the range of diseases that can potentially be 
diagnosed by OCT includes pathologies additional to those macular diseases studied here. We studied a major 
clinical referral pathway in a global center of clinical excellence focusing on 53 key diagnoses relevant to the 
national (NHS) referral pathways. Our work opens up the possibility of testing the clinical applicability of this 
approach in other global settings and clinical pathways such as emergency macular assessment clinics in the UK 
NHS, triage and assessment in community eye care centers and the monitoring of disease during treatment 
regimes. Furthermore, devices such as binocular OCT​33​ have the potential to increase accessibility in emerging 
economies. Images produced by such devices will differ in resolution, contrast and image quality from the 
state-of-the-art devices studied here, and existing AI models trained on current state-of-the-art devices may 
perform poorly on such new devices. Our proposed two-stage model offers exciting possibilities in deploying 
models more efficiently in countries where state-of-the-art OCT devices are too costly for widespread adoption. 
 
In conclusion, we present a novel framework that analyses clinical OCT scans and makes referral suggestions to 
a standard comparable to clinical experts. While focused on one common type of medical imaging, future work 
can address a much wider range of medical imaging techniques, and incorporate clinical diagnoses and tissue 
types well outside the immediate application demonstrated here.  
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Online Methods 
Ethics and Information governance 
This work, and the collection of data on implied consent, received national Research Ethics Committee (REC) 
approval from the Cambridge East REC and Health Research Authority approval (reference 16/EE/0253); it 
complies with all relevant ethical regulations. De-identification was performed in line with the Information 
Commissioner’s Anonymization: managing data protection risk code of practice 
(https://ico.org.uk/media/1061/anonymisation-code.pdf), and validated by the Moorfields Eye Hospital 
Information Technology and Information Governance departments respectively. Only de-identified retrospective 
data was used for research, without the active involvement of patients. 
 
Further details on the methods are described in a published protocol describing the DeepMind collaboration with 
Moorfields Eye Hospital​43​.  
 
Visualization of Results in Clinical Practice 
To facilitate viewing of the results in routine clinical practice, we display the obtained three dimensional 
segmentation maps as two-dimensional thickness maps overlaid on a projection of the raw OCT scan (​Fig. 5a​). 
The thickness maps for all tissue types are displayed side-by-side in our interactive OCT viewer (​Fig. 5b ​and 
Supplementary Video 1​). Our system also provides measures for its degree of certainty on both overall referral 
decision, and each specific retinal disease feature. In most common clinical scenarios, the algorithm will both 
provide the diagnosis with a high degree of certainty and highlight classical disease features (e.g. “wet” AMD - 
Supplementary Video 2​). This visualization may be particularly useful in difficult and ambiguous cases, such 
as the diagnosis of CNV formation in cases of chronic central serous retinopathy (CSR, ​Supplementary Videos 
5 ​and ​7​) or in advanced geographic atrophy due to AMD (​Supplementary Video 6​). Such a visualization may 
also allow clinicians to discard an automated diagnosis or referral suggestion in obvious failure cases, such as 
when poor image quality leads to erroneous segmentation results (​Supplementary Video 8​). Furthermore, in a 
screening context the tissue segmentation map can facilitate quality assurance procedures, whether that be in 
normal cases (​Supplementary Video 3​) or in disease cases (e.g., diabetic macular edema in the context of 
diabetic retinopathy screening, ​Supplementary Video 4​).  
  
Datasets and Clinical Taxonomy 
Datasets 
Data were selected from a retrospective cohort of all patients attending Moorfields Eye Hospital NHS 
Foundation Trust, a world renowned tertiary referral center with 32 clinic sites serving an urban, mixed 
socioeconomic and ethnicity population centered around London, U.K., between 1 June 2012 and 31 January 
2017, who had OCT imaging (Topcon 3D OCT, Topcon, Japan; Spectralis, Heidelberg Engineering, Germany) 
as part of their routine clinical care. Conditions with fewer than ten cases, and data from patients who had 
manually requested that their data should not be shared, were excluded before research began. OCT scan sets 
containing severe artefacts, or significant reductions in signal strength to the point where retinal interfaces could 
not be identified were also excluded from the study (​Supplementary Fig. 10​), as such scans are non-diagnostic 
and in practice would usually be retaken. Scans where no diagnostic label could be attached (as described 
below) were excluded from the present study. For OCT examinations labeled as urgent or semi-urgent in the 
Moorfields OpenEyes electronic health record (EHR) only scans taken prior to treatment beginning were 
included; during treatment, resolution of pathology invalidates the database labels. The dataset selection and 
stratification process is displayed in a CONSORT flow diagram in ​Supplementary Fig. 11​.  
 
Two OCT device types were selected for investigation. 3D OCT-2000 (Topcon, Japan) was selected as “device 
type 1” due to its routine use in the clinical pathway we studied. For device type 1, a total of 15,877 OCT scans 
from 7981 individual patients (mean age 69.5; 3686 male, 4294 female, 1 gender unknown) were eligible for 
inclusion in the work (Datasets #3 + #4 in ​Supplementary Table 3​). To create a test set representative of the 
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real-world clinical application, 997 additional patients (mean age 63.1; 443 male, 551 female, 3 gender 
unknown) presenting to Moorfields with visual disturbance during the retrospective period were selected and 
only their referral OCT examination was selected for inclusion in the test set (Dataset #5 in ​Supplementary 
Table 3​); a sample size requirement of 553 to detect sensitivity and specificity at 0.05 marginal error and 95% 
confidence was used to inform the number included. To demonstrate the generalizability of our approach, 
Spectralis OCT (Heidelberg Engineering, Germany) was chosen as “device type 2”. For generalisability 
experiments, a second test set of clinical OCT scans from 116 patients (mean age 58.2; 59 male, 57 female) 
presenting in the same manner were selected using the same methodology and selection criteria (Dataset #11 in 
Supplementary Table 3​). Examples of differences between the two devices types are shown in ​Supplementary 
Fig. 9.​ ​Supplementary Table 8​ shows a breakdown of patients and triage categories in the datasets. 
 
Clinical Taxonomy 
OCT examinations were mapped from individual diagnoses and treatment information to specific triage 
decisions ("urgent referral", "semi-urgent referral", "routine referral", and "observation only") to a medical 
retina clinic setting (​Supplementary Table 1)​. Where possible the presence or absence of additional 
pathologies was added as a label (​Supplementary Table 5​). The dataset represents the full variety of medical 
retina patients presenting and receiving treatment at Moorfields Eye Hospital. Although the exact mapping was 
chosen to be relevant to the triage decisions at Moorfields Eye Hospital where the research work took place, the 
framework is generalisable to other systems at centers with different triage requirements (e.g., optometrists 
working in a high street clinic setting or ophthalmologists without subspecialty retinal expertise). Scans meeting 
the exclusion criteria were removed from the database before splitting the data into training, validation and test 
sets. ​Supplementary Fig. 12​ provides an example of variation within the ‘urgent referral’ label class. 
 
Clinical Labeling 
Clinical labels for the 14,884 scans in Dataset #3 in ​Supplementary Table 3 ​were assigned through an 
automated notes search with trained ophthalmologist and optometrist review of the OCT scans. The presence or 
absence of choroidal neovascularization, referable macular edema, normal and other pathologies visible on the 
OCT scan were recorded. In addition, patients with choroidal neovascularization or macular edema confirmed 
through treatment were labeled directly from the Moorfields OpenEyes electronic health record (EHR). A 
validation subset of 993 scans (993 patients) was graded separately by three junior graders (ophthalmologists 
specializing in medical retina) with disagreement in clinical labels arbitrated by a senior retinal specialist with 
over 10 years experience and image reading center certification for OCT segmentation (Dataset #4 in 
Supplementary Table 3​). The test set was further verified by full notes review with access to follow up data 
with both junior and senior grader review. Junior and senior graders were separate to those participating in the 
evaluation of expert performance. 
 
Manual Segmentation 
A subset of 1101 scans from device type 1 and a set of 264 scans from device type 2 were manually segmented 
using the segmentation editor plugin for ImageJ-Fiji​34​ (Datasets #1 + #2 and Datasets #9 + #10 in 
Supplementary Table 3​). The segmentation labels were chosen to distinguish all relevant diagnoses for the 
referral decision, as well as potential artefacts that may affect the diagnostic quality of all or part of the scan. In 
particular, the current state of art does not differentiate between the three different types of pigment epithelial 
detachment, or segment out areas of fibrosis scarring or blood as hyper-reflective material​27,28​. Anatomical 
delineations and noclamneture are consistent with standard grading criteria for the evaluation of OCT​35–37​. The 
segmentation examples were selected and segmented by ophthalmologists specializing in medical retina as 
representative cases for pathological features. These were reviewed and edited by a senior ophthalmologist with 
over 10 years experience and image reading center certification for OCT segmentation. 3-5 slices per OCT were 
chosen for segmentation, which best represented the pathological features (​Supplementary Table 2​, 
Supplementary Fig. 13, Supplementary Table 9​).  
 
Evaluating the Expert Performance 
To evaluate expert performance on the test set, eight clinical experts were recruited for an evaluation study. 
Participants included four consultant ophthalmologists at Moorfields Eye Hospital with fellowship-level 
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subspecialty training in medical retinal disease and extensive clinical experience (21, 21, 12.5 and 11.5 years of 
experience respectively), and four optometrists at Moorfields Eye Hospital with specialist training in OCT 
interpretation and retinal diseases (15, 9, 6 and 2.5 years of experience respectively). These are referred to as 
retinal specialists 1 to 4 and optometrists 1 to 4 in the rest of the paper (​Supplementary Table 10​). Each expert 
was instructed to provide a triage decision (​Supplementary Table 1​) and to record the presence or absence of 
the defined pathological features (​Supplementary Table 5​). 
 
To assess the performance in a realistic clinical environment, all scans were read in a random order twice with at 
least a week between readings. On the initial review, only the OCT scan was presented (Dataset #7 in 
Supplementary Table 3​). On second review participants were presented with all the information available at 
the time of triage: OCT and fundus scans, age, gender, ethnicity and where available information on visual 
acuity and a short clinical vignette (Dataset #8 in ​Supplementary Table 3​). The model only received the OCT 
scan. 
 
To assess the difference between the test set for device type 1 and device type 2 five clinical experts were 
recruited for a further evaluation study (Dataset #12 in ​Supplementary Table 3​). Participants were five 
consultant ophthalmologists at Moorfields Eye Hospital with fellowship-level subspecialty training in medical 
retinal disease (21, 21, 12.5, 11.5 and 11 years experience respectively). Four were participants in the device 
type 1 evaluation study, while the other was a new participant for this study and is referred to as retina specialist 
five.  
 
Network Architectures and Training Protocol 
Segmentation Network 
The first stage of our framework consists of a segmentation network that takes as input a part of the OCT scan, 
and outputs a part of a segmentation map. That is, it predicts for each voxel one tissue type out of the 15 classes 
described in ​Supplementary Table 2​. At training time, the input of the network consists of 9 contiguous slices 
of an OCT, and the goal of the network is to segment the central slice. The input is therefore a 448x512x9 
voxels image, and the output is an estimated probability over the 15 classes, for each of the 448x512x1 output 
voxels. None of the convolutions made across the slices (z dimension) adds padding to its input. As a result, we 
can exploit shared computations at inference time to predict any number of contiguous slices in parallel, being 
only limited by the memory capacity of the system. 
 
The structure of the segmentation convolutional neural network (CNN) model is shown in ​Supplementary Fig. 
14​. It uses a 3D U-Net architecture​14​, consisting of an analysis (downwards) path, a synthesis (upwards) path, 
and shortcut connections between blocks of the same level and different paths. We have applied four variations 
over it. First, we use 3x3x1 convolutions with padding and 1x1x3 convolutions without padding instead of 
3x3x3 convolutions without padding. Second, downsampling and upsampling operations are carried out through 
parameter-free bilinear interpolation, replacing max-pooling and up-convolution. Third, we have introduced one 
extra residual connection within each block of layers, so that the output of each block consists of the sum of the 
features of the last layer, and the first layer of the block in which the features dimensions match. Finally, the 
middle block of layers between the analysis and synthesis paths is composed of a sequence of fully connected 
layers. The first variation allows us to control the receptive field for z separately and is furthermore less 
computationally expensive. The second and third variation aimed at improving the gradients flow throughout the 
network, which makes the training process easier. The last variation extends the receptive field such that each 
pixel in the output effectively has the whole input contained within its receptive field. 
 
We used per-voxel cross entropy as the loss function, with 0.1 label-smoothing regularization​38​. We have neither 
used dropout nor weight decay as regularisation means, as preliminary experiments showed this did not improve 
the performance. We trained the model in TensorFlow​39​ with the Adam optimizer​40​ for 160000 iterations on 8 
Graphics Processing Units (GPUs) with dataset #1 in ​Supplementary Table 3​ . The initial learning rate was 
0.0001 and set to 0.0001/2 after 10% of the total iterations, 0.0001/4 after 20%, 0.0001/8 after 50%, 0.0001/64 
after 70%, 0.0001/256 after 90% and finally 0.0001/512 for the final 5% of training. All decisions and 
hyper-parameters above were selected on the basis of their performance on a validation set (Dataset #2 in 
Supplementary Table 3​). 
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To improve the generalisation abilities of our model we augmented the data by applying affine and elastic 
transformations jointly over the inputs and ground truth segmentations​13,14​. Intensity transformations over the 
inputs were also applied. 
 
Our segmentation network for device type 2, shown in ​Supplementary Fig. 15​, is trained on scans from both 
devices (Dataset #1 + #9 in ​Supplementary Table 3​) with the aim of leveraging the large number of labeled 
instances for device type 1. It has three changes compared to the architecture for device type 1. First, we 
subsample the input from device type 1 (128 slices) to match the resolution of device type 2 (49 slices) and 
apply slight padding in height to the scans of device type 2 to give them of the same shape in height and width 
as the scans of device type 1. Second, the input first goes through one of two “device adaptation branches”, 
depending on the device type of the input scan. The architecture of this branch consists of three convolutions 
with padding, with one residual connection as in the other blocks, and is identical for both device types (see 
Supplementary Fig. 15​). The network can then simply learn to compensate for the changes between device 
types early on and map them to a common representation. Lastly, the number of feature maps on the first level 
of the analysis path is halved from 32 to 16 such that the overall architecture still has fewer parameters than the 
architecture for device type 1. During training the network was presented with a ratio of 2.5 : 1 for training 
samples from device type 2 : device type 1. All decisions and hyper-parameters above were selected on the basis 
of their performance on a validation set (Dataset #2 + #10 in ​Supplementary Table 3​). 
 
Classification network 
The classification network learns to map a segmentation map to the four referral decisions and the ten additional 
diagnoses (see ​Supplementary Fig. 16​). For device type 1, it takes as input a 300x350x43 subsampling of the 
original 448x512x128 segmentation map created by the segmentation network described above. The output is a 
14-component vector. For device type 2, whose scans originally are 448x512x49, we first upscale the 
segmentation map to the same resolution as for device type 1 and then proceed identically as for device type 1. 
The architecture uses a three-dimensional version of the dense blocks described by Huang et al​41​ using 3x3x1 
and 1x1x3 convolutions. The details of its structure are shown in ​Supplementary Fig. 16​. We found using 
dense convolution blocks to be critical for training classification networks on large 3d volumes. The inputs are 
one-hot encoded and augmented by random 3d affine and elastic transformations​14​. The loss was the sum of the 
softmax cross entropy loss for the first four components (multi-class referral decision) and the sigmoid cross 
entropy losses for the remaining ten components (additional diagnoses labels). We also used a small amount 
(0.05) of label-smoothing regularisation​38​ and added some (1e-5) weight decay. We trained the model in 
TensorFlow​39​ with the Adam optimiser​40​ for 160000 iterations of batch size 8 spread across 8 GPUs with 1 
sample per GPU with dataset #3 in ​Supplementary Table 3​. The initial learning rate was 0.02 and set to 0.02/2 
after 10% of the total iterations, 0.02/4 after 20%, 0.02/8 after 50%, 0.02/64 after 70%, 0.02/256 after 90% and 
finally 0.02/512 for the final 5% of training. All decisions and hyper-parameters above were selected on the 
basis of their performance on a validation set (Dataset #4 in ​Supplementary Table 3​). 
 
Ensembling 
For both of these networks we trained 5 instances: we trained the same network with a different order of the 
inputs and different random weight initialisations​42​. The experiments of Lakshminarayanan et al​42​ suggest that 5 
instances are sufficient in most settings, so we also used this number. For our experiments, we applied the 5 
instances of our segmentation model to the input scan resulting in 5 segmentation maps. The 5 instances of our 
classification model were then applied to each of the segmentation maps, resulting in a total of 25 classification 
outputs per scan, as illustrated in ​Supplementary Fig. 1​. The results reported are obtained after averaging the 
probabilities estimated by these models. 
 
Optimizing the Ensemble Output for Sensitivity, Specificity and Penalty Scores  
For different applications, the preferred compromise between a high hit rate (sensitivity) and a low false alarm 
rate (1-specificity) can be different. For the binary diagnosis decisions, we computed an optimal rescaling factor 
a​ for the pseudo-probabilities, such that a 50% threshold achieves maximal (sensitivity+specificity)/2 on the 
validation set (Dataset #4 in ​Supplementary Table 3​). The rescaling was done by ​p = aq / (aq + (1-a)(1-q)), 
where ​q​ denotes the ensemble output and ​p​ the reweighted probability.​ ​We used (sensitivity+specificity)/2 
instead of the total accuracy to avoid the bias due to the low number of patients with positive condition in the 
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validation set (and in the test set). For a balanced set with equal numbers of positive and negative samples this 
term is exactly the accuracy. 
 
For the four-way referral decision (where the highest probability wins), we optimized four scaling factors using 
the validation set to reduce the overall cost specified by the misclassification penalty matrix (​Supplementary 
Fig. 6​). A first set of factors was optimized for a balance between high accuracy and low penalty points 
(referred to as "​our model (1)" ​in ​Supplementary Fig. 6.​), a second set of factors was optimized for penalty 
cost only (referred to as "​our model (2)" ​in ​Supplementary Fig. 6​). The cost matrix for the balanced 
performance was computed by averaging the normalized cost matrix for accuracy (a matrix with 0 in the 
diagonal elements and 1 in the off-diagonal elements) and the normalized penalty cost matrix. Normalisation 
was performed by dividing the matrix by the sum of all elements. The optimisation of the four factors was done 
with the Adam optimiser using a softmax layer and a weighted cross-entropy loss layer. 
 
End-to-End Classification Network 
The network architecture for the end-to-end classification experiments was identical to the architecture of the 
classification network in the two-stage approach (see ​Section "classification network" ​and ​Supplementary 
Fig. 16​) with a small adaption. To roughly obtain the same number of parameters, we added a dense layer (two 
convolutions with 7 channels output each) that translates the single-channel raw OCT to a 14-channel feature 
map. All selected hyper parameters and augmentation strategies were identical to the original classification 
network. We trained 5 network instances on the training set with 14,884 raw OCT scans from device type 1 
(Dataset #13 in ​Supplementary Table 3​). Each network instance was initialized with different random weights 
and was presented with the training images in a different order. After training we also computed an optimal 
reweighting on the validation set (as we did for the two-stage model) and tested the ensemble on the test set. 
 
 
Statistical Analysis 
Significant Differences Using a Two-Sided Exact Binomial Test 
The comparison of our model's performance to the expert's performance is based on the assumption that our 
model and the expert have an unknown but constant performance. That is, every inspected eye scan is correctly 
diagnosed by our model with the probability​ p​mod​, and correctly diagnosed by the expert with probability ​p​exp​. 
For ​N​ eye scans the number of correct diagnoses ​k is ​therefore binomially distributed with Pr(​k​) = B(​k​ | ​p, N​). If 
our model achieves ​k​mod​ correct diagnoses and the expert achieves ​k​exp​ correct diagnoses, the probability that the 
true performance of our model ​p​mod​ is higher than the true performance of the expert ​p​exp ​is 
 
 
 
The probability for a lower performance, i.e. ​Pr( p​mod​ <  ​p​exp​ | ​k​mod​, k​exp​, N)​ is derived analogously. For all 
comparisons, a confidence level of 95% was used. The formula was numerically integrated using in-house code.  
Reporting Summary 
Further information on experimental design is available in the Nature Research Reporting Summary linked to 
this article. 
Code Availability 
The codebase for the deep learning framework makes use of proprietary components and we are unable to 
publicly release this code. However, all experiments and implementation details are described in sufficient detail 
in the methods section and in Supplementary Figures to allow independent replication with non-proprietary 
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libraries. 3D augmentation code (using the caffe framework) is available as part of the 3D U-net source code at 
https://lmb.informatik.uni-freiburg.de/resources/opensource/unet.en.html​. Additionally, although we are unable 
to make all the Google proprietary components available, we are in the process of making the augmentation 
operations for TensorFlow available in the official TensorFlow code. 
Data availability 
The clinical data used for the training, validation and test sets were collected at Moorfields Eye Hospital and 
transferred to the DeepMind data center in the UK in de-identified format. Data were used with both local and 
national permissions. They are not publicly available and restrictions apply to their use. The data, or a test 
subset, may be available from Moorfields Eye Hospital NHS Foundation Trust subject to local and national 
ethical approvals. 
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Abbreviations 
AMD: Age related macular degeneration 
AUC: Area under the curve 
classif.: classification 
CNN: Convolutional neural network 
CNV: Choroidal neovascularization 
CONSORT: Consolidated Standards of Reporting Trials 
conv: convolution 
CSR: Central serous retinopathy 
DME: Diabetic macular edema 
EHR: Electronic health record 
ERM: Epiretinal membrane 
ETDRS: Early Treatment Diabetic Retinopathy Study 
full mac. hole: Full thickness macular hole 
GA: Geographic atrophy 
geo. atrophy: Geographic atrophy 
GPU: Graphics Processing Unit 
hyper reflect. mat.: hyperreflective material  
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MacTel: Macular telangiectasia 
MEH: Moorfields Eye Hospital 
MRE: Macular retinal edema 
NHS: National Health Service 
OCT: Optical coherence tomography 
part. mac. hole: Partial thickness macular hole 
PED: Pigment epithelium detachment 
perf.: performance 
pred.: predicted 
QA: Quality Assurance 
RAP: Retinal angiomatous proliferation 
REC: Research Ethics Committee 
ROC: Receiver operating characteristic 
RPE: Retinal pigment epithelium 
segm.: segmentation 
Val.: Validation 
VMT: Vitreomacular traction 
voxel: Volumetric picture element 
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Supplementary Information 
Supplementary Figures 
 
 
 
 
 
 
 
Supplementary Figure 1 | Generating predictions with an ensemble of segmentation and classification networks. 
Illustration showing how the ensemble of 5 segmentation network instances and 5 classification network instances are jointly 
used to generate 25 predictions for one scan. Each segmentation network instance first provides a segmentation map 
hypothesis based on the input OCT. For each of these 5 segmentation map hypotheses every classification network instance 
provides a probability for each label, here shown in detail for the geographic atrophy label. 
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Supplementary Figure 2 | Example information available to the experts to make the referral decision.​ (​a​) Full OCT scan 
with a slider to scroll through the slices. (​b​) Fundus image. (​c​) Patient summary notes. Scale bars: 1mm 
 
 
 
 
 
Supplementary Figure 3 | ​Receiver operating characteristic (ROC) diagrams for referral decisions.​ (​a​) Urgent and 
semi-urgent referral versus routine referral and observation only (n=997 patients). The blue ROC curve is created by sweeping 
a threshold over the predicted probability (or the measured segmentation volume in case of Drusen and epiretinal membrane 
(ERM)). Points outside the light blue area correspond to a significantly different performance (95% confidence level, using a 
two-sided exact binomial test). Filled markers denote expert's performance using OCT only; empty markers denote their 
performance using OCT, fundus image and summary notes. Dashed lines connect the two performance points of each expert. 
(​b​) Urgent, semi-urgent and routine referral versus observation only (n=997 patients) 
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Supplementary Figure 4 | Confusion matrices for the referral decision for all 8 experts. ​n=997 patients. 
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Supplementary Figure 5 | ​Error rate of the referral decision on device type 1.​ The error rate is shown for the device type 1 
test set​ ​(dataset #5 in ​Supplementary Table 3​) for different numbers of model instances in the ensemble. The error rate was 
computed as the average over all possible combinations of N x M segmentation and classification model instances out of the 5 
x 5 instances that are used in the rest of this study. The performance differences between 4 x 4 instances and 5 x 5 instances 
are only marginal (n=997 patients) 
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Supplementary Figure 6 | Adverse consequences of wrong referral decisions.​ (​a​) Our proposed penalty points for a wrong 
referral decision. In the first row the penalty points correspond approximately to the number of weeks that a CNV patient might 
lose in referral time before treatment (with 100 as a maximum for a patient triaged as ‘observation’ and would not be called 
back for assessment). The penalty points in the other rows are selected relative to this, with the additional constraint that an 
overdiagnosis (lower left triangle) is considered less harmful to an individual than an underdiagnosis. (​b​) Average penalty points 
per patient according to our proposed penalty metrics. Framework (1) is optimized for balanced performance; framework (2) is 
optimized for a better penalty score (n=997 patients, error bars indicate 95% confidence interval, computed from the standard 
error of the sample mean) (​c​) Distribution of the collected penalty points for our models and the experts (n=997 patients) in the 
same layout as above. The colored parts of each bar indicate the amount of penalty points collected in each category. 
 
 
 
 
 
 
Supplementary Figure 7 | ​Confusion matrix of an end-to-end classification network applied to the test set​ (dataset #5 in 
Supplementary Table 3​). The results were obtained by an ensemble of 5 model instances (n=997 patients). 
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Supplementary Figure 8 | Receiver operating characteristic (ROC) diagrams for the additional pathologies. ​The blue 
ROC curve is created by sweeping a threshold over the predicted probability (or the measured segmentation volume in case of 
Drusen and ERM). n=997 patients. Points outside the light blue area correspond to a significantly different performance (95% 
confidence level, using a two-sided exact binomial test). Filled markers denote expert's performance using OCT only; empty 
markers denote their performance using OCT, fundus image and summary notes. Dashed lines connect the two performance 
points of each expert. 
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Supplementary Figure 9 | Differences between the two device types.​ The scans taken by device type 2 (Heidelberg 
Spectralis) have obvious differences in appearance compared to those taken by device type 1 (Topcon 3D OCT). The higher 
contrast in device type 2 results in better feature definition which could mislead segmentation models trained only on device 
type 1. Arrowheads in each image show the differences between device types 1 & 2 respectively. (​a​) Posterior hyaloid. (​b​) 
Intraretinal fluid. (​c​) Geographic atrophy. (​d​) Fibrovascular PED. (​e​) Drusen. In addition, in all images the choroid - the area 
below the retina at the bottom of the images - is better defined with device type 2. While this has benefits for diagnosis the 
differences can confuse models which may mistake the differences for additional retinal layers. Scale bars: 0.5mm 
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Supplementary Figure 10 | Excluded and included cases in the test set.​ (​a​) The three cases excluded from the test set due 
to insufficient signal in the OCT. Every 10th slice of the OCT scan is displayed. Note that in all cases the retina is either absent 
(empty scan) or barely visible, preventing the interpretation of the scan. (​b​) Four examples of cases that were included in the 
test set despite being of poor quality, or representing complex pathology​.​ Scale bars: 1mm 
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Supplementary Figure 11 | Sample selection at Moorfields Eye Hospital (MEH). ​Manual opt outs are not included as none 
of the patients who manually opted out had digital OCT within the study dates. 
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Supplementary Figure 12 | Five examples of patients in the test set with choroidal neovascularization (CNV).​ All images 
from the test set (n=997) show CNV requiring urgent referral with corresponding segmentations from our segmentation network 
(​color legend in ​Supplementary Table 2)​. (​a​) A patient with choroidal neovascularization in the context of CSR. (​b​) A patient 
with choroidal neovascularization resulting from age related macular degeneration (AMD). ​(c)​ A patient with extensive 
fibrovascular pigment epithelium and subretinal hyperreflective material. (​d​) A patient with large amounts of subretinal 
hyperreflective material in the context of CNV. (​e​) A highly ambiguous case with a possible retinal angiomatous proliferation 
(RAP) lesion in a myopic patient. Scale bars: 0.5mm 
 
 
 
 
 
 
 
Supplementary Figure 13 | Examples of the segmentation model output for ten different retinal pathologies. ​2D slices of 
OCT scans in the segmentation test set (n=224) with corresponding manual and predicted segmentation maps for the ten 
pathology classes included in our study (​color legend in ​Supplementary Table 2)​. Classes are not mutually exclusive and 
multiple pathologies may be present in a single scan. (​a​)​ ​A normal retina as it appears in an OCT scan. (​b​)​ ​A patient with 
choroidal neovascularization due to age related macular degeneration. The segmentation map shows the area of fibrovascular 
pigment epithelium detachment associated with neovascularization. (​c​)​ ​Diabetic maculopathy and referable macular edema. (​d​) 
Geographic atrophy in late age related macular degeneration. (​e​)​ ​Drusen in early age related macular degeneration. (​f​) 
Vitreomacular traction. (​g​)​ ​Central serous retinopathy. Note that the segmentation model correctly identifies the pigment 
epithelium detachment as serous material. (​h​)​ ​A patient with epiretinal membrane.​ (​i​) ​Full thickness macular hole. (​j​) Partial 
thickness macular hole​. Scale bars:  0.5mm 
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Supplementary Figure 14 | 3D U-Net model used in the first stage of our approach. ​At training time, the model receives 9 
contiguous OCT slices. Blue boxes illustrate the 4D activation maps. Colored arrows stand for the different operations. 
 
 
 
 
 
 
 
 
 
Supplementary Figure 15 | 2-branch U-Net for device type 2. ​The architecture of our segmentation network with “device 
adaptation branches” to segment scans of device type 2. In the top left we show an enlarged version of the differences 
compared to the original architecture for device type 1 (shown in ​Supplementary Fig. 14​). Blue boxes illustrate the 4D 
activation maps with the number of channels shown below. Green arrows denote convolutional operations. We train on scans 
from both device type 1 and device type 2 but subsample those from device type 1 in the z-dimension to match the lower 
z-resolution of device type 2. Depending on which device the scan is from, the scan first goes through either the top branch, for 
device type 1, or the bottom branch, for device type 2. The output of the chosen branch is then used as input to a modified 
version of the first level of the analysis path of the original architecture. The rest of the architecture is identical. 
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Supplementary Figure 16 | Classification CNN (convolutional neural network) used in the second stage of our 
approach​. Blue and red boxes illustrate the 4D activation maps. Blue boxes are the result of a (3x3x1) convolution, while red 
boxes are the result of a (1x1x3) convolution. 
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Supplementary Tables 
 
Supplementary Table 1 | ​Taxonomy of referral classes 
 
Referral 
Category Definition 
Urgent All causes of choroidal neovascularization, including age related macular degeneration, 
high myopia, central serous retinopathy, inherited retinal dystrophies (e.g., angioid 
streaks), posterior uveitis (e.g., multiple choroiditis), and post traumatic choroidal 
rupture. 
Semi-urgent Referable edema classed as semi-urgent included diabetic maculopathy, retinal vein 
occlusion, postoperative (Irvine-Gass syndrome), uveitis, Coat’s disease, radiation and 
miscellaneous other cases. 
Routine All other non-urgent cases with a large variety, from uncomplicated central serous 
retinopathy to more rare conditions such as Macular Telangiectasia (MacTel) type 2. 
Observation 
only 
The absence of pathology classes described above. 
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Supplementary Table 2 | ​Taxonomy of segmentation regions 
 
   Training Test 
Color Feature Definition 
Total number 
of scans with 
label 
segmented 
Percent 
of total 
voxels 
Total number 
of scans with 
label 
segmented 
Percent 
of total 
voxels 
 
Vitreous and 
subhyaloid 
Area above the internal limiting 
membrane not covered by other 
segmentation classes 
856 20.63 220 20.30 
 
Posterior hyaloid Hyperreflective membrane visible 
above the retina in cases of posterior 
vitreous detachment 
356 0.12 95 0.13 
 
Epiretinal 
membrane 
Hyperreflective band seen on the 
inner surface of the retina, often 
associated with distortion of the 
underlying neurosensory retina 
326 0.06 95 0.04 
 
Neurosensory 
retina 
All layers and contents of the retina, 
excluding the pathological features 
described below 
856 10.76 220 11.12 
 
Intraretinal fluid Areas of round or oval 
hyporeflectivity located within the 
neurosensory retina 
356 0.59 111 0.76 
 
Subretinal fluid Hyporeflective areas in the subretinal 
space - the space below the 
neurosensory retina but above the 
retinal pigment epithelium 
255 0.48 68 0.33 
 
Subretinal hyper 
reflective material 
Areas of hyperreflectivity between 
the retinal and RPE 92 0.12 22 0.08 
 
Retinal pigment 
epithelium (RPE) 
Hyperreflective band underlying the 
neurosensory retina 853 0.92 220 0.95 
 
Drusenoid 
pigment 
epithelium 
detachment (PED) 
Elevation of the RPE, often 
dome-shaped, with a hypo- or 
medium-reflective material 
separating the RPE from the 
underlying Bruch’s membrane, and 
without the presence of fibrovascular 
material 
268 0.07 61 0.06 
 
Serous PED Dome-shaped elevation of the retinal 
pigment epithelium relative to 
Bruch’s membrane, typically seen 
overlying a homogeneously 
hyporeflective space devoid of 
fibrovascular material 
58 0.02 11 0.003 
 
Fibrovascular 
PED 
Irregular elevations of the retinal 
pigment epithelium relative to 
Bruch’s membrane containing 
fibrovascular tissue of variable 
reflectivity 
183 0.37 45 0.54 
 
Choroid and outer 
layers 
Area below the RPE not covered by 
other segmentation classes 854 51.26 220 51.56 
 
Mirror artefact Artefact caused by patient anatomy 
out of the OCT frame being reflected 
back onto the OCT 
9 0.01 3 0.02 
 
Clipping artefact Padding voxels introduced at the 
edges of OCT slices during image 
processing 
877 7.21 224 7.36 
 
Blink artefact Absent information due to patient 
blink 22 7.38 5 6.75 
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Supplementary Table 3​ | ​Overview of datasets used for training, validation and testing of the different networks 
 
 
Dataset 
Device 
type 
Number 
of scans Input Labels Label source 
#1 Training set for 
segmentation 
1 877 OCT scans  Sparse segm. maps  
(3-5 slices per scan) 
Manually segmented by trained 
ophthalmologists, reviewed and edited 
by a senior ophthalmologist. 
#2 Validation set for 
segmentation 
1 224 OCT scans Sparse segm. maps  
(3-5 slices per scan) 
Manually segmented by trained 
ophthalmologists, reviewed and edited 
by a senior ophthalmologist. 
#3 Training set for 
classification 
1 14884 dense segm. maps, 
created automatically 
from OCT scans  
(5 segm. maps per 
scan) 
Diagnoses and referral 
decision 
Automated notes search + trained 
ophthalmologist and optometrist review 
of the OCT scans. 
#4 Validation set for 
classification 
1 993 dense segm. maps, 
created automatically 
from OCT scans 
Diagnoses and referral 
decision 
Graded by three junior graders. 
Disagreement in clinical labels arbitrated 
by a senior grader. 
#5 Test set:  
Referral gold 
standard 
1 997 OCT scans Referral decision Full patient clinical records to determine 
the final diagnosis and optimal referral 
pathway in the light of that 
(subsequently obtained) information. 
#6 Test set: 
Diagnoses silver 
standard 
(same OCT scans as #5) Diagnoses Majority vote from 8 experts (4 retinal 
specialists and 4 optometrists) grading 
using OCT scan, fundus image and 
clinical notes 
#7 Human results: 
Experts on OCT 
only 
(same OCT scans as #5) Diagnoses and referral 
decision from 8 experts 
8 experts (4 retinal specialists and 4 
optometrists) grading on OCT scan only 
#8 Human results: 
Experts on OCT + 
fundus + notes 
(same OCT scans as #5) Diagnoses and referral 
decision from 8 experts 
8 experts (4 retinal specialists and 4 
optometrists) grading on OCT scan, 
fundus image and clinical notes 
#9 Training set 2 for 
segmentation 
2 152 OCT scans Sparse segm. maps  
(3-5 slices per scan) 
Manually segmented by trained 
ophthalmologists, reviewed and edited 
by a senior ophthalmologist. 
#10 Validation set 2 for 
classification 
2 112 OCT scans Referral decision Full patient clinical records to determine 
the final diagnosis and optimal referral 
pathway in the light of that 
(subsequently obtained) information. 
#11 Test set 2: 
Referral gold 
standard 
2 116 OCT scans Referral decision Full patient clinical records to determine 
the final diagnosis and optimal referral 
pathway in the light of that 
(subsequently obtained) information. 
#12 Human results: 
Experts on OCT + 
fundus + notes 
(same OCT scans as #11) Referral decision from 
5 experts 
5 retinal specialists grading on OCT 
scan, fundus image and clinical notes 
#13 Training set for 
end-to-end model  
(same cases as #3) OCT scans                          (same labels as #3) 
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Supplementary Table 4​ | ​Overview of the OCT scan sizes used in this study. All sizes are given in A-scan, B-scan, C-scan 
direction 
 
Dataset 
image  
size [voxels] 
real world  
voxel size [µm] 
real world  
image size [mm] comments 
device type 1 raw OCT scans 885 · 512 · 128 2.6 · 11.7 · 47.2 2.3 · 6.0 · 6.0  
segmentation network  
input / output 
448 · 512 · 128 5.2 · 11.7 · 47.2  device type 1 scans resampled in A-scan 
direction to 5.2µm voxel size, and 
zero-padded to the next multiple of 64 (added 
6 pixels) 
classification network input 300 · 350 · 43 7.8 · 17.6 · 141.7  segmentation map resampled to 7.8µm · 
17.6µm · 141.7µm voxel size such that the 
full classification network fits into GPU 
memory  
device type 2 raw OCT scans 496 · 512 · 49 3.9 · 11.3 · 120 1.93 · 5.79 · 5.88  
2-branch segmentation network 
input / output 
448 · 512 · 49 5.2 · 11.7 · 120  device type 2 scans resampled in A,B-scan 
direction to 5.2µm · 11.7µm voxel size, and 
padded accordingly; 
device type 1 scans resampled in C-scan 
direction to 120µm voxel size. 
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Supplementary Table 5 | ​Taxonomy of diagnostic labels 
 
Condition Definition 
Normal Absence of pathology. 
Macular retinal edema 
(MRE) 
Referable retinal edema, seen in the OCTs as intraretinal and 
subretinal fluid. 
Choroidal 
neovascularization (CNV) 
New vessel growth from the choroidal layer of the eye; associated 
with a variety of retinal conditions including neovascular age related 
macular degeneration, severe myopia and central serous retinopathy. 
Drusen Acellular polymorphous deposits in Bruch’s membrane; the most 
common early sign of dry age-related macular degeneration. 
Geographic atrophy Loss of the retinal pigment epithelium with variable loss of the 
overlying photoreceptors and underlying choriocapillaris; a sign of 
late stage dry age-related macular degeneration. 
Central serous retinopathy 
(CSR) 
A disease where increased choroidal permeability leads to a build up 
of subretinal fluid, causing a detachment of the neurosensory retina. 
Full thickness macular hole A round, full-thickness defect of retinal tissue in the foveal retina, 
leading to loss of central vision. 
Partial thickness macular 
hole 
A partial thickness defect of retinal tissue in the foveal retina. 
Vitreomacular traction 
(VMT) 
A disorder of the vitreoretinal interface where an incomplete 
posterior vitreous detachment exerts tractional pull on the macula 
and results in morphologic alterations and consequent 
metamorphopsia or central visual loss. 
Epiretinal membrane (ERM) Fibrocellular tissue found on the inner surface of the retina which 
may be idiopathic or secondary to various retinal conditions. Small 
epiretinal membranes may not be clinically significant, and may be 
considered a normal aging feature. 
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Supplementary Table 6 ​| Same as table before but experts have access to OCT + fundus image + full summary notes. 
 
Diagnosis 
Area under 
ROC curve 
[percent] 
N positive 
samples 
Experts with 
significantly higher 
performance 
Experts with 
indistinguishable 
performance 
Experts with 
significantly 
lower 
performance 
CNV 99.25 252 -   
MRE 99.03 240 -   
normal 99.51 242    
full mac. 
hole 
100.0 46 -  - 
part.mac. 
hole 
99.92 31 -  - 
CSR 99.49 44   - 
VMT 97.95 46   - 
geographic 
atrophy 
99.02 51   - 
Drusen 97.42 
 (from segm.) 
170   - 
ERM  96.63 
 (from segm.) 
118   - 
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Supplementary Table 7 ​| Performance on additional diagnoses of experts using OCT only to our framework. The ground truth 
for CNV is derived from the full follow-up patient files. The ground truth for the other diagnoses is computed as majority vote 
from the 8 experts. Drusen and ERM predictions were derived directly from the segmentation map. Circles represent retinal 
specialists, triangles represent optometrists. 
 
Diagnosis 
Area under 
ROC curve 
[percent] 
N positive 
samples 
Experts with 
significantly 
higher 
performance 
Experts with 
indistinguishable 
performance 
Experts with 
significantly lower 
performance 
CNV 99.25 252 -    
MRE 99.03 240 -   
normal 99.51 242    
full mac. 
hole 
100.0 46 -  - 
part. mac. 
hole 
99.92 31 -    
CSR 99.49 44  -  - 
VMT 97.95 46   - 
geographic 
atrophy 
99.02 51   - 
Drusen  97.42  
(from segm.) 
170 -    
ERM 96.63  
(from segm.) 
118   - 
 
 
 
 
Supplementary Table 8 | ​Total OCT examinations (unique patients in brackets) in the dataset by triage category.  
 
Triage category Training Validation Test  (Device Type 1) 
Test  
(Device Type 2) 
Urgent 4832 (3039) 251 (237) 252 (252) 34 (34) 
Semi-urgent 3438 (1854) 268 (259) 230 (230) 28 (28) 
Routine 5223 (1927) 247 (236) 266 (266) 35 (35) 
Observation only 1391 (801) 227 (195) 249 (249) 19 (19) 
Total 14884 (7621) 993 (927) 997 (997) 116 (116) 
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Supplementary Table 9​ | ​Number of cases of referral classes in the training and validation set for the segmentation network for 
OCT device type 1. 
 
Referral Category Number in Training Set Number in Validation Set 
Urgent 227 58 
Semi-Urgent 182 57 
Routine 89 20 
Observation 379 89 
Total 877 224 
 
 
 
 
 
Supplementary Table 10 ​| The experience and position of the nine experts against which the algorithm was compared. 
 
Expert Position 
Years of 
Experience 
1 Consultant Ophthalmologist in Medical Retina 21 
2 Consultant Ophthalmologist in Medical Retina 21 
3 Consultant Ophthalmologist in Medical Retina 12.5 
4 Consultant Ophthalmologist in Medical Retina 11.5 
5 Specialist Optometrist, Medical Retina 15 
6 Specialist Optometrist, Medical Retina 9 
7 Specialist Optometrist, Medical Retina 6 
8 Specialist Optometrist, Medical Retina 2.5 
9 Consultant Ophthalmologist in Medical Retina 10 
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Supplementary Videos 
Supplementary​ ​Video 1 - OCT viewer​ | ​This video demonstrates the interaction with the OCT viewer. The OCT scan belongs 
to a 72 year old female presented with increasing visual distortion over a 4 month period; the OCT shows loss of RPE 
consistent with geographic atrophy. The view first goes through the whole volume (128 slices) for a fixed tissue map 
hypothesis, followed by showing the different tissue map hypotheses for a given slice. Finally, we let the collage cycle through 
the different hypotheses continually while scrolling through the volume, pausing on several slices briefly to show the variations. 
The color legend for all segmentation maps is available in ​Supplementary Table 2. 
 
Supplementary Video 2 - wet AMD | ​Choroidal neovascularization (CNV) is the pathognomonic feature of the neovascular 
(“wet”) form of age-related macular degeneration (AMD) and requires urgent treatment to prevent irreversible visual loss. A 
72-year old man presented with a history of reduced vision in his left eye. Best corrected visual acuity in the affected eye was 
38 Early Treatment Diabetic Retinopathy Study (ETDRS) letters. The model correctly selects the Most Urgent Diagnosis as 
“CNV”, suggesting referral to an ophthalmologist on an urgent basis. The model segmentation highlights growth of the 
neovascular tissue in the sub-retinal pigment epithelium (RPE) space – a so-called fibrovascular pigment epithelium 
detachment (PED). Subretinal fluid can be seen surrounding the inferior margins of the fibrovascular PED indicating the 
presence of ongoing CNV leakage.  
 
Supplementary Video 3 - Normal |​ Scans are quick and safe to perform and are thus commonly used in the screening of 
patients without visual symptoms or other ophthalmic findings. A 46-year old man who was referred for retinal specialist review. 
Best corrected visual acuity was 6/6. The model correctly selects the referral decision as “Observation Only”, suggesting that 
the OCT findings in isolation do not require referral to an ophthalmologist. The model accurately delineates the neurosensory 
retina without the presence of any pathologic compartments. It also highlights partial separation of the posterior hyaloid of the 
vitreous – this is a normal finding as the vitreous gel increasingly liquefies with age. 
 
Supplementary Video 4 - Diabetic Macular Edema | ​Accumulation of this fluid in the macula – diabetic macular edema (DME) 
– is the commonest cause of visual impairment in diabetes. A 54-year old man with diabetes was referred to Moorfields for 
ophthalmologist review with best corrected visual acuity in the affected eye of 45 ETDRS letters. The model correctly detects 
the presence of macular retinal edema (MRE) and suggests semi-urgent ophthalmology referral. The model highlights 
intraretinal fluid accumulation, with cystoid spaces in both the inner nuclear and outer plexiform layers, and a mixed 
petaloid/honeycomb appearance on the en face images. There is also an accompanying significant increase in total retinal 
thickness.  
 
Supplementary Video 5 - Ambiguous Case (chronic CSR) | ​In chronic CSR, diagnosis of secondary CNV formation is often 
challenging due to the frequent presence of shallow irregular pigment epithelium detachments (PEDs). A 60-64 year old woman 
presented with a history of CSR in her left eye. The model correctly detects the presence of CSR but is far less certain about 
the presence of CNV. It highlights a gravitational tract of subretinal fluid with a discrete area of fibrovascular PED superior to the 
fovea. 
 
Supplementary Video 6 - Ambiguous Case (advanced geographic atrophy) | ​In advanced forms of AMD, geographic 
atrophy (GA) may sometimes coexist with CNV formation. In such cases, the CNV component may be clinically silent, and the 
fundus appearance may be limited to that of GA, making the diagnosis difficult. A 84-year old man was referred to Moorfields. 
Best corrected visual acuity in the affected eye was 1/60. The ground truth diagnosis was GA and routine referral was 
recommended. While the model correctly diagnoses the presence of GA and drusen, it suggests urgent referral due to the 
possible presence of CNV. The presence of subretinal hyperreflective on model segmentation is suggestive of previous CNV 
formation.  
 
Supplementary Video 7 - Difficult Case of CNV | ​A 30 year old male patient, with a known history of CSR, presented with 
acute visual loss in his left eye and was diagnosed with secondary CNV formation. At this visit, the OCT scans lack many of the 
prototypical features of CSR, such as subretinal fluid accumulation. The model correctly diagnoses the presence of CNV and 
suggests the presence of CSR, but with far less certainty.  
 
Supplementary Video 8 - Failure case (partial thickness macular hole) | ​Ocular media opacities may sometimes cause 
artefactual reductions in OCT signal strength and this can make accurate image segmentation challenging. Due to localized 
reduction in OCT signal strength in this case, some of the models erroneously detect the presence of a partial thickness 
macular hole. As a result, the models are uncertain as to whether the eye is normal or whether routine referral is required. 
 
Supplementary Video 9 - Integration with other clinical information | ​Retinal angiomatous proliferation (RAP) is a variant of 
choroidal neovascularization (CNV) due to age-related macular degeneration (AMD). A 75-79 year old woman presented with 
reduced vision in her left eye. The model segmentation highlights the presence of a fibrovascular pigment epithelium 
detachment (PED) with subretinal hyperreflective material, overlying intraretinal fluid, and surrounding drusen. These findings 
are highly suggestive of RAP - in its early stages, this can be misdiagnosed as macular retinal edema (MRE), particularly in 
elderly patients with diabetes. The interpretable representation reduces the risk of misdiagnosis and allows the clinician to 
easily correlate these findings with other clinical information, e.g., fundus fluorescein angiography.  
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